A Phase II Study of Osimertinib Combined With Platinum Plus Pemetrexed in Patients With EGFR-Mutated Advanced Non–Small-cell Lung Cancer: The OPAL Study (NEJ032C/LOGIK1801)
収録刊行物
-
- Clinical Lung Cancer
-
Clinical Lung Cancer 22 (2), 147-151, 2021-03
Elsevier BV